trial

Cannabinoids, Neural Synchrony, and Information Processing

NCTId NCT00708994
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Early Phase 1 · Completed
Enrollment 42 (actual)
Sponsored by Yale University
Primary completion 2012-12-03
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Early Phase 1
Status
Completed
Enrollment
42 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Quadruple
Start
2008-02-25
Primary completion
2012-12-03
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
THC

Sponsors

Yale UniversityLead Sponsor
National Institute on Drug Abuse (NIDA)Collaborator

Investigators

1
Deepak Cyril D'Souza, MDPrincipal Investigator

Sites

1 total
West Haven, United States

Facts & assertions

4 sourced
Enrollment
42
Phase
EARLY_PHASE1
Primary Completion Date
2012-12-03
Status
COMPLETED
relationships
The graph out of here
drug
THC
drug
lead_sponsor
Yale University
company
collaborator
National Institute on Drug Abuse (NIDA)
company
indication
Psychotic Disorders
indication
Psychotic Disorders
indication
Cannabis
indication
investigator
Deepak Cyril D'Souza, MD
person